|
Headline: New Market strives to stay ahead Source: Euromoney Date: June 2000 Author: Philip Moore Biotechs and pharmaceuticals have so far dominated the SWX New Market, attracting institutional investors rare in other new technology markets. But while it may be ahead for the moment, the Swiss exchange is faced with strong competition from the fusion of growth exchanges in the rest of Europe, and the Nasdaq link-up. Philip Moore reports Ed Peter, head of Swiss equities at Deutsche Bank’s Zurich office, reckons Switzerland is “five years ahead of Germany” in corporate restructuring and the delivery of shareholder value. |
Access intelligence that drives action
To unlock this research, enter your email to log in or enquire about access
